In the News

Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health

Xealth has announced an additional $24 million in Series B funding, bringing its total raised to $52.6 million. The funding round was led by Advocate Aurora Enterprises, with additional participation from seven health systems--Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health, and...

Oncology Analytics Announces Rebrand to OncoHealth

Oncology Analytics has changed its name to OncoHealth, a forward-looking rebrand for the company’s vision of the future and its focus on helping people through their cancer journey. "OncoHealth represents our evolution of better aligning the way we serve clients and the way our clients access...

New multi-cancer early detection blood test study opens

The University of Oxford has opened a new study, which will trial a new multi-cancer early detection (MCED) blood test for early detection of more than 50 types of cancer. The study, SYMPLIFY, is also open at Oxford University Hospitals (OUH) and already includes more...

Hims & Hers Expands Women’s Health Offerings With Support For Urinary Tract Health

Hims & Hers, a multi-specialty telehealth platform focused on providing personalized health and wellness experiences to customers, recently expanded its women’s health offerings with the recent launch of a D-Mannose dietary supplement powder to support urinary tract health on ForHers.com. “Roughly 3 or 4 in 10...

Following Strong Growth, Hims & Hers Appoints Chief Growth Officer

On the heels of strong Q2 earnings, Hims & Hers Health, Inc., has appointed Mike Chi as the company’s first-ever chief growth officer. Chi brings years of experience in the women’s market and will be responsible in this new role for driving continued growth across...